Nomura Adjusts Shenzhen Mindray Bio-Medical's Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy
Nomura Adjusts Shenzhen Mindray Bio-Medical's Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy
野村将深圳迈瑞生物医疗的目标股价从423.39元调整至441.20元人民币，维持买入状态
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间